These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 19321593

  • 1. c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome.
    Bagnoli M, Ambrogi F, Pilotti S, Alberti P, Ditto A, Barbareschi M, Galligioni E, Biganzoli E, Canevari S, Mezzanzanica D.
    Endocr Relat Cancer; 2009 Jun; 16(2):443-53. PubMed ID: 19321593
    [Abstract] [Full Text] [Related]

  • 2. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S.
    Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424
    [Abstract] [Full Text] [Related]

  • 3. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
    Borgoño CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP.
    Clin Cancer Res; 2006 Mar 01; 12(5):1487-93. PubMed ID: 16533772
    [Abstract] [Full Text] [Related]

  • 4. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
    Tan XJ, Lang JH, Lou WZ, Shen K, Xu XY.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr 01; 30(4):274-8. PubMed ID: 18788631
    [Abstract] [Full Text] [Related]

  • 5. Analysis of potential prognostic factors in 111 patients with ovarian cancer.
    Hornung R, Urs E, Serenella E, Edward W, Ursula S, Urs H, Daniel F.
    Cancer Lett; 2004 Mar 31; 206(1):97-106. PubMed ID: 15019165
    [Abstract] [Full Text] [Related]

  • 6. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
    Eltabbakh GH, Belinson JL, Kennedy AW, Biscotti CV, Casey G, Tubbs RR, Blumenson LE.
    Cancer; 1997 Sep 01; 80(5):892-8. PubMed ID: 9307189
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients.
    Ullenhag GJ, Mukherjee A, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG.
    Clin Cancer Res; 2007 Sep 01; 13(17):5070-5. PubMed ID: 17785559
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax).
    de la Torre FJ, García A, Gil-Moreno A, Planaguma J, Reventos J, Ramón y Cajal S, Xercavins J.
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan 01; 130(1):121-8. PubMed ID: 16876311
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E, Sabo E, Naroditsky I, Sova Y, Lavie O, Resnick MB.
    Gynecol Oncol; 2006 Jan 01; 100(1):152-9. PubMed ID: 16198399
    [Abstract] [Full Text] [Related]

  • 13. A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma.
    Kowalski LD, Kanbour AI, Price FV, Finkelstein SD, Christopherson WA, Seski JC, Naus GJ, Burnham JA, Kanbour-Shakir A, Edwards RP.
    Cancer; 1997 Apr 15; 79(8):1587-94. PubMed ID: 9118043
    [Abstract] [Full Text] [Related]

  • 14. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
    Zhang MZ, Qiao YH, Suo ZH.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):848-52. PubMed ID: 19173831
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinoma.
    Tanabe H, Nishii H, Sakata A, Suzuki K, Mori Y, Shinozaki H, Watanabe A, Ochiai K, Yasuda M, Tanaka T.
    Gynecol Oncol; 2004 Sep 15; 94(3):735-9. PubMed ID: 15350366
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic value of p53 accumulation in epithelial ovarian carcinomas.
    Berker B, Dunder I, Ensari A, Cengiz SD.
    Arch Gynecol Obstet; 2002 Aug 15; 266(4):205-9. PubMed ID: 12192480
    [Abstract] [Full Text] [Related]

  • 20. B7-H4 overexpression in ovarian tumors.
    Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR.
    Gynecol Oncol; 2006 Jan 15; 100(1):44-52. PubMed ID: 16256178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.